🔗 Permalink

Inventor profile of:

Cindy Castado

City:

Rixensart

Country:

Belgium

Published Applications:

Last publication date:

2023-09-21

Top Assignees for applications by Cindy Castado

The entities that hold a legal rights for patent applications filed by inventor Castado Cindy:

GlaxoSmithKline Biologicals S.A. 23 Rixensart, Belgium
GLOXOSMITHKLINE BIOLOGICALS, S.A. 1 Rixensart, Belgium
GLAXOSMITHKLINE 1 RIXENSART, Belgium

Recent patent applications by Castado Cindy

Cindy Castado from Rixensart, BE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-09-21

US20230293659A1

Human necessities

TRUNCATED FUSOBACTERIUM NUCLEATUM FUSOBACTERIUM ADHESIN A (FADA) PROTEIN AND IMMUNOGENIC COMPOSITIONS THEREOF

#2 | 2022-09-01

US20220273789A1

Human necessities

THERAPEUTIC VIRAL VACCINE

#3 | 2021-07-22

US20210220462A1

Human necessities

IMMUNOGENIC PROTEINS AND COMPOSITIONS

#4 | 2020-10-15

US20200325184A1

Chemistry; metallurgy

UspA2 protein constructs and uses thereof

#5 | 2020-07-23

US20200230226A1

Human necessities

Viral antigens

#6 | 2020-06-11

US20200179504A1

Human necessities

IMMUNOGENIC COMPOSITION FOR USE IN VACCINATION AGAINST STAPHYLOCOCCI

#7 | 2020-04-23

US20200123571A1

Chemistry; metallurgy

Compositions and methods of treatment

#8 | 2019-03-14

US20190076516A1

Human necessities

Immunogenic composition for use in vaccination against staphylococci

#9 | 2018-12-13

US20180354996A1

Chemistry; metallurgy

UspA2 protein constructs and uses thereof

#10 | 2018-02-15

US20180043005A1

Human necessities

IMMUNOGENIC COMPOSITION COMPRISING ELEMENTS OF C. DIFFICILE CDTB AND/OR CDTA PROTEINS

#11 | 2017-12-21

US20170362309A1

Chemistry; metallurgy

Nucleotide sequences, vectors and host cells

#12 | 2017-10-12

US20170290905A1

Human necessities

VACCINE

#13 | 2017-08-31

US20170247421A1

Chemistry; metallurgy

Nucleotide sequences, vectors and host cells

#14 | 2017-08-03

US20170218031A1

Chemistry; metallurgy

CLOSTRIDIUM DIFFICILE IMMUNOGENIC COMPOSITION

#15 | 2017-07-27

US20170209562A1

Human necessities

IMMUNOGENIC COMPOSITION

#16 | 2017-01-12

US20170008932A1

Chemistry; metallurgy

UspA2 protein constructs and uses thereof

#17 | 2016-06-09

US20160159867A1

Chemistry; metallurgy

Nucleotide sequences, vectors and host cells

#18 | 2015-11-19

US20150328302A1

Human necessities

IMMUNOGENIC COMPOSITION FOR USE IN VACCINATION AGAINST STAPHYLOCOCCEI

#19 | 2015-11-05

US20150313985A1

Human necessities

Immunogenic composition comprising elements of C. difficile CDTb and/or CDTa proteins

#20 | 2015-05-07

US20150125481A1

Human necessities

Immunogenic Composition

#21 | 2014-06-26

US20140178424A1

Chemistry; metallurgy

Immunogenic composition

#22 | 2014-04-03

US20140093529A1

Chemistry; metallurgy

Immunogenic composition

#23 | 2013-02-21

US20130045231A1

Human necessities

Immunogenic composition

#24 | 2013-01-10

US20130011429A1

Human necessities

IMMUNOGENIC COMPOSITION

#25 | 2013-01-03

US20130004530A1

Human necessities

VACCINE COMPOSITION

#26 | 2012-06-07

US20120141523A1

Human necessities

IMMUNOGENIC COMPOSITION COMPRISING ANTIGENIC S. AUREUS PROTEINS

#27 | 2011-01-13

US20110008385A1

Human necessities

Immunogenic composition

#28 | 2008-12-18

US20080311146A1

Human necessities

Immunogenic Composition

#29 | 2008-04-24

US20080095777A1

Human necessities

Immunogenic Composition for Use in Vaccination Against Staphylococcei

#30 | 2008-04-10

US20080085289A1

Human necessities

Immunogenic Composition

#31 | 2007-05-24

US20070116711A1

Human necessities

Pertussis antigens and use thereof in vaccination

#32 | 2005-06-02

US20050118659A1

Chemistry; metallurgy

Novel compounds

InventorID:

10746 ⎘